ISSN: 0973-7510

E-ISSN: 2581-690X

Review Article | Open Access
Akriti Goel1, Garima1, Navidha Aggarwal1 , Garima Kapoor2,
Hitesh Chopra3, Mamta Naagar1, Aishwarya Gangwar1, Prachi Singh4 and Kuldeep Dhama5
1MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, India.
2KIET School of Pharmacy, KIET Group of institution Delhi-NCR, Ghaziabad, Uttar Pradesh, India.
3Chitkara College of Pharmacy, Chitkara University, Punjab, India.
4Department of Veterinary Microbiology, College of Veterinary Sciences, Uttar Pradesh Pandit Deen Dayal Upadhyaya Pashu Chikitsa Vigyan Vishwavidyalaya Evam Go Anusandhan Sansthan (DUVASU), Mathura- 281001, India.
5Division of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, India.
Article Number: 8479 | © The Author(s). 2023
J Pure Appl Microbiol. 2023;17(1):89-111.
Received: 04 February 2023 | Accepted: 25 February 2023 | Published online: 02 March 2023

Skin and soft tissue infections are brought on by invasion of microbes on the skin and underlying soft tissues (SSTIs). They appear in a series of shapes, causes the high level of severeness. Differentiating between SSTI situations that require prompt attention and surgical or medical intervention from those that don’t is difficult. SSTIs are most prevalent in emergency rooms and affect 7% to 10% of hospitalised patients. SSTIs are characterised by inflammatory components as well as other symptoms including fever, quickly growing lesions, and bullae. The creation of a severity categorization approach to specify suitable empirical treatment would improve the management of SSTIs. Based on the patient’s status knowledge of potential infections, an antibiotic medicine is chosen. Oral antibiotics are sufficient for simple mild-to-moderate infections; however, intravenous antibiotics are required for complicated severe infections.


Infection, Skin, Soft-tissue, Pathogenesis, Treatment, Epidemiology

Article Metrics

Article View: 37

Share This Article

© The Author(s) 2023. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.